These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 8359577

  • 1. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ, Lattimer SA, Kamijo M, Van Huysen C, Sima AA, Greene DA.
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [Abstract] [Full Text] [Related]

  • 2. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 3. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K, Kato N, Matsubara A, Nakano K, Kurono M.
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [Abstract] [Full Text] [Related]

  • 4. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 5. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 6. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 7. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K.
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [Abstract] [Full Text] [Related]

  • 8. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H, Tawata M, Aida K, Onaya T.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [Abstract] [Full Text] [Related]

  • 9. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D, Lattimer SA, Nolle S, Bernstein M, Greene DA.
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.
    Stevens MJ, Henry DN, Thomas TP, Killen PD, Greene DA.
    Am J Physiol; 1993 Sep; 265(3 Pt 1):E428-38. PubMed ID: 8214052
    [Abstract] [Full Text] [Related]

  • 11. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.
    Greene DA, Lattimer SA.
    Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432
    [Abstract] [Full Text] [Related]

  • 12. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.
    Lowitt S, Malone JI, Salem AF, Korthals J, Benford S.
    Metabolism; 1995 May; 44(5):677-80. PubMed ID: 7752919
    [Abstract] [Full Text] [Related]

  • 13. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR, Hawthorne JN.
    Life Sci; 1983 Apr 25; 32(17):1943-7. PubMed ID: 6835015
    [Abstract] [Full Text] [Related]

  • 14. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L, Day N, Peterson RG, Eichberg J.
    Metabolism; 1996 Mar 25; 45(3):320-7. PubMed ID: 8606638
    [Abstract] [Full Text] [Related]

  • 15. Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.
    Kato N, Mizuno K, Makino M, Suzuki T, Yagihashi S.
    Diabetes Res Clin Pract; 2000 Oct 25; 50(2):77-85. PubMed ID: 10960717
    [Abstract] [Full Text] [Related]

  • 16. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG.
    Diabetes; 1989 May 25; 38(5):569-79. PubMed ID: 2497038
    [Abstract] [Full Text] [Related]

  • 17. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA.
    Int J Exp Diabetes Res; 2002 May 25; 3(1):21-36. PubMed ID: 11900277
    [Abstract] [Full Text] [Related]

  • 18. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR, Robinson JP, Compton AM, Keen P.
    Diabetologia; 1989 Sep 25; 32(9):655-9. PubMed ID: 2477293
    [Abstract] [Full Text] [Related]

  • 19. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
    Kato N, Mizuno K, Matsubara A, Nakano K, Kurono M, Yagihashi S.
    J Diabetes Complications; 1994 Sep 25; 8(1):27-32. PubMed ID: 8167384
    [Abstract] [Full Text] [Related]

  • 20. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI, Lowitt S, Corsico N, Orfalian Z.
    Int J Clin Pharmacol Res; 1992 Sep 25; 12(5-6):237-41. PubMed ID: 1301404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.